Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
12
|
0.700 |
strong |
1.000 |
23 |
12
|
1977 |
2014 |
THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA
|
disease |
|
Disease or Syndrome
|
1
|
5
|
0.700 |
None |
1.000 |
11 |
5
|
2000 |
2018 |
ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
strong |
1.000 |
6 |
3
|
2000 |
2018 |
Anemia due to decreased red cell production
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Myeloid Proliferations Associated with Down Syndrome
|
disease |
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Fetal thrombotic vasculopathy
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
THROMBOCYTOPENIA, X-LINKED, WITH DYSERYTHROPOIETIC ANEMIA
|
disease |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
THROMBOCYTOPENIA, X-LINKED, WITHOUT DYSERYTHROPOIETIC ANEMIA
|
disease |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Dyserythropoietic Anemia with Thrombocytopenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
3
|
0.430 |
None |
1.000 |
9 |
3
|
1996 |
2014 |
Transient Myeloproliferative Disorder of Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2013 |
Crisis state
|
phenotype |
|
Mental or Behavioral Dysfunction
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Overt Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Congenital dyserythropoietic anemia type IV
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Abnormality of multiple cell lineages in the bone marrow
|
disease |
|
Anatomical Abnormality
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Neonatal leukaemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Congenital erythroid hypoplasia
|
disease |
|
Congenital Abnormality
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Deficiency of Uroporphyrinogen III Synthase
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
3
|
2
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Acute Basophilic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.320 |
None |
1.000 |
2 |
|
2011 |
2019 |
Adult Acute Basophilic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2019 |
Childhood Acute Basophilic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2019 |
Myeloid leukemia associated with Down Syndrome
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2020 |
Tetrasomy 21
|
disease |
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Atlantoaxial instability
|
disease |
|
Disease or Syndrome
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Hemoglobin increased
|
phenotype |
Neoplasms; Hemic and Lymphatic Diseases
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
trisomy 2
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |